---
$id: https://graph.org.ai/products/commodity/51111743
$type: Product
source: UNSPSC
code: "51111743"
title: "Medorubicin"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Medorubicin

**UNSPSC Code**: 51111743
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthracycline antibiotic with the molecular formula C26H27NO10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NU158DGH9E, chemically known as 5,12-naphthacenedione, 7,8,9,10-tetrahydro-7-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-9-(hydroxyacetyl)-6,9,11-trihydroxy-, (7s-cis)- but generally known as medorubicin, which bears US NIH Compound Identifier 68837. European Medicines Agency schedules Medorubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08695MIG. The term MEDORUBICIN is an International Non-Proprietary Name. MEDORUBICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule medorubicin under HS 29419000 and SITC 54139. As of Q4 2014, MEDORUBICIN remains the US FDA Preferred Term for this commodity. Medorubicin bears US NLM identifiers UMLS ID C0048224 and NCI Concept Code C87599. SMILES: O(C1CC(O)(CC2C1C(O)C1C(C2O)C(=O)C2C(C1=O)CCCC2)C(=O)CO)C1OC(C(O)C(N)C1)C.

